What is a stock summary page? Click here for an overview.
Business Description
X Bioscience PCL
ISIN : TH0753B10Z01
Description
X Bioscience PCL is engaged in investment in food and beverages business and the group are engaged in selling food and beverages, and manufacturing and selling biological products. The group operates in two business segments: the food and beverage sales segment and the internal management services segment provided by the parent company. The group operates in a single geographic area, which is Thailand. The company's brand consists of Kagonaya, Bake, and Leboeuf.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.03 | |||||
| Equity-to-Asset | 0.36 | |||||
| Debt-to-Equity | 0.69 | |||||
| Debt-to-EBITDA | -2.01 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -1.74 | |||||
| Beneish M-Score | -2.42 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -7 | |||||
| 3-Year EPS without NRI Growth Rate | -18.2 | |||||
| 3-Year FCF Growth Rate | 39.2 | |||||
| 3-Year Book Growth Rate | -31.6 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 67.24 | |||||
| 9-Day RSI | 46.64 | |||||
| 14-Day RSI | 36.48 | |||||
| 3-1 Month Momentum % | -48.57 | |||||
| 6-1 Month Momentum % | -74.12 | |||||
| 12-1 Month Momentum % | -71.38 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.25 | |||||
| Quick Ratio | 0.22 | |||||
| Cash Ratio | 0.02 | |||||
| Days Inventory | 16.44 | |||||
| Days Sales Outstanding | 8.49 | |||||
| Days Payable | 174.35 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -33.7 | |||||
| Shareholder Yield % | -232.98 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 43.42 | |||||
| Operating Margin % | -78.69 | |||||
| Net Margin % | -81.51 | |||||
| FCF Margin % | -23.11 | |||||
| ROE % | -99.9 | |||||
| ROA % | -28.91 | |||||
| ROIC % | -21.22 | |||||
| 3-Year ROIIC % | -520.17 | |||||
| ROC (Joel Greenblatt) % | -82.06 | |||||
| ROCE % | -51.63 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.35 | |||||
| PB Ratio | 0.48 | |||||
| EV-to-EBIT | -3.75 | |||||
| EV-to-EBITDA | -5.18 | |||||
| EV-to-Revenue | 2.87 | |||||
| EV-to-FCF | -12.1 | |||||
| Price-to-GF-Value | 0.16 | |||||
| Price-to-Median-PS-Value | 0.14 | |||||
| Earnings Yield (Greenblatt) % | -26.69 | |||||
| FCF Yield % | -29.01 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return %
Total Annual Return %
X Bioscience PCL Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ฿) | 319.244 | ||
| EPS (TTM) (฿) | -0.251 | ||
| Beta | 1.55 | ||
| 3-Year Sharpe Ratio | -1.44 | ||
| 3-Year Sortino Ratio | -1.46 | ||
| Volatility % | 74.07 | ||
| 14-Day RSI | 36.48 | ||
| 14-Day ATR (฿) | 0.015236 | ||
| 20-Day SMA (฿) | 0.1225 | ||
| 12-1 Month Momentum % | -71.38 | ||
| 52-Week Range (฿) | 0.1 - 0.733679 | ||
| Shares Outstanding (Mil) | 2,119.14 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
X Bioscience PCL Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
X Bioscience PCL Stock Events
| Event | Date | Price (฿) | ||
|---|---|---|---|---|
| No Event Data | ||||
X Bioscience PCL Frequently Asked Questions
What is X Bioscience PCL(BKK:XBIO)'s stock price today?
The current price of BKK:XBIO is ฿0.12. The 52 week high of BKK:XBIO is ฿0.73 and 52 week low is ฿0.10.
When is next earnings date of X Bioscience PCL(BKK:XBIO)?
The next earnings date of X Bioscience PCL(BKK:XBIO) is .
Does X Bioscience PCL(BKK:XBIO) pay dividends? If so, how much?
X Bioscience PCL(BKK:XBIO) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers